METTL16 and breast carcinoma: Similarly, METTL16 is highly expressed in breast cancer patient tissues, and its knockdown not only inhibits BC cell proliferation in vitro and tumor growth in vivo but also significantly increases intracellular iron (Fe2+) and lipid reactive oxygen species (ROS) levels, indicating induction of ferroptosis.